Learning objectives
Upon successful completion of this educational activity, participants should be able to: 
Provider
This activity is provided by prIME Oncology.
Continuing education prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. prIME Oncology designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity was approved by the ONS, an accredited approver by the American Nurses Credentialing Center's COA.
A maximum of 1 contact hour may be earned for successful completion of this program. Successful completion includes reviewing the journal supplement and completing the evaluation.
Content in this learning activity is applicable to meeting individual requirements for certification renewal through the Oncology Nursing Certification Corporation's Independent Learning Needs Assessment (ILNA) renewal method. Visit www.oncc.org for complete details on oncology nursing certification.
Method of participation and request for credit
There are no fees for participating in and receiving CME credit for this activity. In order to receive credit, participants must successfully complete the online posttest and activity evaluation. Your participation in this CME activity will be recorded in prIME Oncology's database. However, upon request, your CME credit certificate will be emailed to you.
Please visit https://goo.gl/mszn1P to take the posttest. In order to claim credit for this activity, a score of 75% or higher is required.
Disclosure of relevant financial relationships prIME Oncology assesses relevant financial relationships of its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. Any potential conflicts of interest that are identified are thoroughly vetted by prIME Oncology for fairness, balance, and scientific objectivity of data, as well as patient care recommendations. prIME Oncology is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial entity.
The faculty reported financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.
The employees of prIME Oncology have disclosed: 
Disclosure of unlabeled use
This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration or European Medicines Agency. Please refer to the official prescribing information for each product discussed for discussions of approved indications, contraindications, and warnings.
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Financial Support This educational activity is supported by grants from Merck and Co, Inc. and TESARO, Inc.
